Results 61 to 70 of about 243,277 (388)

Placental Growth Factor Levels in Preeclampsia Compared to Normal Pregnancy

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2015
Objective: To identify and analyze the differences in the levels of PlGF in preeclampsia and normal pregnancy. Method: This was a cross-sectional observational qualitative study of PlGF in preeclampsia and normal pregnancy. The number of samples in
Dumaria Situmorang   +2 more
doaj   +1 more source

Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study. [PDF]

open access: yesPLoS ONE, 2017
OBJECTIVES:Preeclampsia is divided into early-onset (delivery before 34 weeks of gestation) and late-onset (delivery at or after 34 weeks) subtypes, which may rise from different etiopathogenic backgrounds.
Pia M Villa   +11 more
doaj   +1 more source

Advancing hypertensive disorders of pregnancy management: insights from the 5th preeclampsia scientific symposium in Ghana

open access: yesBMC Proceedings
The 5th Preeclampsia Scientific Symposium (PSS2023) organized by Action on Preeclampsia (APEC) Ghana was themed: ‘Realign, Refocus: Improving outcomes of Hypertensive Disorders of Pregnancy through Shared Decision Making, Research & Quality of Care’.
Koiwah Koi-Larbi   +6 more
doaj   +1 more source

Integrated Analysis Identifies Four Genes as Novel Diagnostic Biomarkers Which Correlate with Immune Infiltration in Preeclampsia

open access: yesJournal of Immunology Research, 2022
Preeclampsia remains a high cause of incidence and death for mothers and fetuses in developing nations. Preeclampsia has numerous clinical and biochemical markers that have been tested, but they have failed to provide a conclusive diagnosis in the ...
Mu-yi Yang   +3 more
doaj   +1 more source

Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction. [PDF]

open access: yes, 2020
The human placenta is a poorly-understood organ, but one that is critical for proper development and growth of the fetus in-utero. The epithelial cell type that contributes to primary placental functions is called "trophoblast," including two main ...
Farah, Omar   +3 more
core   +2 more sources

Analysis of the Longitudinal Behavior of Serum Levels of Soluble Flt1 and Placental Growth Factor in Pregnant Patients With Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective This study analyzed longitudinal trajectories of soluble Flt1 (sFlt1) levels, placenta growth factor (PlGF) levels, and sFlt1:PlGF ratios in a cohort of pregnant patients with systemic lupus erythematosus (SLE). Methods Blood samples were collected (14–18, 24–26, 30–32, 34–36, and 38–40 weeks), stored at −80°C, and evaluated for serum levels ...
Nilson R. de Jesús   +7 more
wiley   +1 more source

CADENCE’S DEFENSE MECHANISM IN RECOVERING HER LOST MEMORY IN WE WERE LIARS BY E. LOCKHART [PDF]

open access: yes, 2016
LA PREECLAMPSIA DIFERENCIAS EPIDEMIOLÓGICAS ENTRE PREECLAMPSIA DE INICIO TEMPRANO (PRECOZ) CON PREECLAMPSIA DE INICIO TARDÍO DIFERENCIAS CLÍNICAS ENTRE PIP Y PIT INVASIÓN TROFOBLÁSTICA DEFICIENTE, LA HIPOPERFUSIÓN PLACENTARIA ANÁLISIS DE ANTECEDENTES ...
Soegijono, MegalisthaPratiwi
core   +1 more source

Decreasing resistance in the maternal uterine and peripheral arterial system is apparently unrelated to plasma and urinary levels of nitrite/nitrate and cyclic-guanosinmonophosohate during the course of normal pregnancies [PDF]

open access: yes, 2003
Aims: The aim of the presented study was to clarify the relationship between the pulsatility index of the uterine arteries and the maternal cubital artery and peripheral concentrations of the metabolites of nitric oxide (NO) and its second messenger ...
Bidlingmaier, M.   +5 more
core   +1 more source

Cellular immune responses in the pathophysiology of preeclampsia

open access: yesJournal of Leukocyte Biology, 2021
Preeclampsia, defined as new‐onset hypertension accompanied by proteinuria occurring at 20 weeks of gestation or later, is a leading cause of perinatal morbidity and mortality worldwide.
Derek Miller   +6 more
semanticscholar   +1 more source

Recommendations for the Use of Disease‐Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review

open access: yesArthritis Care &Research, EarlyView.
Objective Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease‐modifying antirheumatic drugs (DMARDs) has fostered more suitable conditions for pregnancy; however, this is accompanied by challenges in ensuring safe use in reproductive ...
Athena Chin   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy